MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
-
Practice Guideline
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licensed by the U. S. Food and Drug Administration (FDA) on May 25, 2006. ⋯ A booster dose is not licensed for the vaccine. Zoster vaccination is not indicated to treat acute zoster, to prevent persons with acute zoster from developing PHN, or to treat ongoing PHN. Before administration of zoster vaccine, patients do not need to be asked about their history of varicella (chickenpox) or to have serologic testing conducted to determine varicella immunity.